Product Information
AMLODIPINE-ATORVAST 10-80 MG is a generic product labeled by Prasco Laboratories, priced at $1.5651 per EA under NDC 66993027330. Its NADAC has been published 201 times since Jun 1, 2022.
FDA first approved this application on Jan 30, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 80 mg/1; mg/1
Manufacturer
Prasco LaboratoriesNDC
66993027330
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021540FDA Approved
1/30/2004
TE Code
AB
On Market Since
3/14/2022
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 10-80 MG has been published 201 times since Jun 1, 2022, and over the history we have for it it has declined 61.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5651 per EA |
|---|---|
| All-time high | $4.0268 (Feb 15, 2023) |
| All-time low | $1.5651 (Sep 23, 2026) |
| 52-week high | $2.1966 |
| 52-week low | $1.5651 |
| Median price | $2.0889 |
| Average price | $2.5031 |
| Largest weekly change | -30.3% (Apr 17, 2024) |
| Weeks tracked | 201 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Prasco Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amlodipine and Atorvastatin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 10-80 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 10-80 MG, manufactured by Prasco Laboratories, is $1.5651 per EA (NDC 66993027330), effective Sep 30, 2026.
How has the price of AMLODIPINE-ATORVAST 10-80 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 10-80 MG has declined 61.1%. It has been tracked across 201 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 10-80 MG?
Since Jun 1, 2022, the NADAC for AMLODIPINE-ATORVAST 10-80 MG has ranged from a low of $1.5651 (Sep 23, 2026) to a high of $4.0268 (Feb 15, 2023), with a median of $2.0889 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 10-80 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-ATORVAST 10-80 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-ATORVAST 10-80 MG?
AMLODIPINE-ATORVAST 10-80 MG (NDC 66993027330) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.